Pharma · ETF · UCITS comparison

Pharma ETF Comparison 2026:
Healthcare UCITS ETFs

The cleanest way to spread the patent-cliff risk: a healthcare ETF bundles many companies into one product. Here are the main UCITS healthcare ETFs for EU investors.

The main healthcare UCITS ETFs compared

ETFISINIndexTER p.a.Distribution
Xtrackers MSCI World Health Care 1CIE00BM67HK77MSCI World Health Care~0.25%accumulating
iShares MSCI World Health Care Sector Advanced (Dist)IE00BJ5JNZ06MSCI World HC Advanced Select (ESG screen)~0.18%distributing
Xtrackers MSCI Europe Health Care 1CLU0292103222MSCI Europe Health Care~0.17%accumulating

Verification as of June 2026. TER/share classes can change — check the current KID before buying.

How to pick the right one

Why an ETF over single stocks: the very risk that hits pharma single stocks hardest — the patent cliff — is what an ETF diversifies away. If one company falls on a patent expiry, the others carry. For most investors that's the calmer pharma solution.
📊 More context: Pharma hub (Dividend Kings, patent cliff) · Defensive investing · Dividend Strategy

FAQ

What is the best pharma ETF for European investors?

For broad, cheap world exposure the Xtrackers MSCI World Health Care (IE00BM67HK77, ~0.25%, accumulating). For distributions the iShares MSCI World Health Care Advanced (IE00BJ5JNZ06, ~0.18%, distributing).

Why an ETF instead of single stocks?

The biggest pharma risk is the patent cliff. An ETF bundles many companies — if one drops out, the others carry. You spread exactly the risk that hits single stocks hardest.

Pharma ETF or broad healthcare ETF?

Most ETFs track the whole healthcare sector (pharma, biotech, medtech) — broader and more robust than pure pharma. An MSCI World Health Care ETF also covers J&J, for instance.

Not financial advice. The ETFs mentioned are examples, not buy or sell recommendations. Investing carries price risk up to total loss. TER/share-class data without warranty, as of June 2026 — check the current KID.